Home > Healthcare > Medical Devices > Therapeutic Devices > U.S. Wound Care Market

U.S. Wound Care Market Share

Report ID: GMI7555
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

U.S. Wound Care Market Share

The U.S. wound care industry is consolidated, with key players including, Smith & Nephew, B. Braun Melsungen AG, and others dominating the market space. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in September 2021, Omeza announced that the U.S. FDA had approved its Omeza collagen matrix. This matrix is made of hydrolyzed fish collagen and is used to treat chronic wounds such as diabetic ulcers, surgical wounds, and partial and full-thickness wounds.

Some of the eminent market participants operating in the U.S. wound care industry include:

Smith & Nephew
Molnlycke Health Care AB
ConvaTec Group PLC
Ethicon (Johnson & Johnson)
Baxter International
URGO Medical
Coloplast Corp.
Medtronic plc
3M Company
Derma Sciences Inc. (Integra LifeSciences)
Medline Industries
Advancis Medical
B. Braun Melsungen AG

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The U.S. wound care industry was valued at USD 8 billion in 2022 and is estimated to reach USD 13.9 billion by 2032 driven by the increasing incidence of burn injuries and diabetes.

The acute wounds segment garnered USD 4.5 billion in 2022 and is expected to grow at a lucrative pace by 2032 owing to diabetic foot ulcers being commonly treated using moist wound dressings, and the rising prevalence of diabetes.

The advanced wound dressing segment garnered USD 2.3 billion in 2022 and will continue to witness demand owing to the adaptability and efficacy in wound treatment.

Smith & Nephew, M